Literature DB >> 34672940

Proportion of clinically significant prostate cancer diagnosed by systematic template biopsy after negative pre-biopsy multiparametric magnetic resonance imaging and predictive value of prostate-specific antigen density.

Mohammad Haroon1, Paul Sathiadoss1, Rodney H Breau1, Ilias Cagiannos1, Trevor Flood1, Luke T Lavallee1, Christopher Morash1, Nicola Schieda1.   

Abstract

Entities:  

Year:  2022        PMID： 34672940      PMCID： PMC8923885          DOI： 10.5489/cuaj.7455

Source DB:  PubMed          Journal:  Can Urol Assoc J        ISSN： 1911-6470            Impact factor:   1.862


× No keyword cloud information.
  5 in total

1.  Avoiding Unnecessary Biopsy: MRI-based Risk Models versus a PI-RADS and PSA Density Strategy for Clinically Significant Prostate Cancer.

Authors:  Dominik Deniffel; Gerard M Healy; Xin Dong; Sangeet Ghai; Emmanuel Salinas-Miranda; Neil Fleshner; Robert Hamilton; Girish Kulkarni; Ants Toi; Theodorus van der Kwast; Alexandre Zlotta; Antonio Finelli; Nathan Perlis; Masoom A Haider
Journal:  Radiology       Date:  2021-05-25       Impact factor: 11.105

Review 2.  PI-RADS Version 2: A Pictorial Update.

Authors:  Andrei S Purysko; Andrew B Rosenkrantz; Jelle O Barentsz; Jeffrey C Weinreb; Katarzyna J Macura
Journal:  Radiographics       Date:  2016-07-29       Impact factor: 5.333

3.  Negative Prebiopsy Magnetic Resonance Imaging and Risk of Significant Prostate Cancer: Baseline and Long-Term Followup Results.

Authors:  Julie Buisset; Joseph M Norris; Philippe Puech; Xavier Leroy; Nassima Ramdane; Elodie Drumez; Arnauld Villers; Jonathan Olivier
Journal:  J Urol       Date:  2020-10-20       Impact factor: 7.450

4.  What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort.

Authors:  Joseph M Norris; Lina M Carmona Echeverria; Simon R J Bott; Louise C Brown; Nick Burns-Cox; Tim Dudderidge; Ahmed El-Shater Bosaily; Eleni Frangou; Alex Freeman; Maneesh Ghei; Alastair Henderson; Richard G Hindley; Richard S Kaplan; Alex Kirkham; Robert Oldroyd; Chris Parker; Raj Persad; Shonit Punwani; Derek J Rosario; Iqbal S Shergill; Vasilis Stavrinides; Mathias Winkler; Hayley C Whitaker; Hashim U Ahmed; Mark Emberton
Journal:  Eur Urol       Date:  2020-05-01       Impact factor: 20.096

5.  Risk-adapted biopsy decision based on prostate magnetic resonance imaging and prostate-specific antigen density for enhanced biopsy avoidance in first prostate cancer diagnostic evaluation.

Authors:  Ivo G Schoots; Anwar R Padhani
Journal:  BJU Int       Date:  2020-11-13       Impact factor: 5.588
  5 in total
  1 in total

1.  Comparative Analysis of PSA Density and an MRI-Based Predictive Model to Improve the Selection of Candidates for Prostate Biopsy.

Authors:  Juan Morote; Angel Borque-Fernando; Marina Triquell; Anna Celma; Lucas Regis; Richard Mast; Inés M de Torres; María E Semidey; José M Abascal; Pol Servian; Anna Santamaría; Jacques Planas; Luis M Esteban; Enrique Trilla
Journal:  Cancers (Basel)       Date:  2022-05-11       Impact factor: 6.575
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.